Innovations in pediatric dosage forms via 3D printing: Chewing lozenges as an example
Abstract
Three-dimensional (3D) printing offers a versatile platform for producing personalized, age-appropriate dosage forms that address the specific therapeutic and administration needs of the pediatric population. Among several oral dosage forms that can be prepared by 3D printing, chewing lozenges offer numerous advantages, especially for the pediatric population. This study illustrates a formulation development and selection of process parameters for 3D-printed chewing lozenges containing propranolol hydrochloride as a model drug, with potential application in the pediatric population. It also highlights the advantages of 3D printing using the semi-solid material extrusion method. Gelatin and sodium alginate were used as carriers for 3D printing. Immersion time in the calcium chloride solution (tim) and lozenges shape were varied, while the following tests were performed: the assessment of organoleptic properties, mass and thickness variations, melting and disintegration time, drug content and dissolution rate. Initially, the key 3D printing parameters for lozenge production were identified, and then the appropriate formulation was selected. Subsequent testing demonstrated that the shape of lozenges, along with variations in tim, influenced the pharmaceutical-technological characteristics. A formulation based on the combination of gelatin and sodium alginate in 1:3 ratio, immersed for 60 seconds in a calcium chloride solution, was found to be suitable for 3D printing of chewable lozenges.
References
Domingues C, Jarak I, Veiga F, Dourado M, Figueiras A. Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies. Pharmaceutics. 2023;15(10):2431.
Jaya Shree S, Saranya P, Vivek A, Srikanth B, Rakshana V, Srinivasan R. Recent Advances and Challenges in the Development of Pediatric Formulations: Review Article. JOPIR. 2024;2(5):28–38.
Yackey K, Stukus K, Cohen D, Kline D, Zhao S, Stanley R. Off-label Medication Prescribing Patterns in Pediatrics: An Update. Hosp Pediatr. 2019;9(3):186–93.
Gore R, Chugh PK, Tripathi CD, Lhamo Y, Gautam S. Pediatric Off-Label and Unlicensed Drug Use and Its Implications. Curr Clin Pharmacol. 2017;12(1):18–25.
Balan S, Hassali MA, Mak VSL. Challenges in pediatric drug use: A pharmacist point of view. Res Social Adm Pharm. 2017;13(3):653–5.
Ranmal SR, Walsh J, Tuleu C. Poor-tasting pediatric medicines: Part 1. A scoping review of their impact on patient acceptability, medication adherence, and treatment outcomes. Front Drug Deliv. 2025;5:1553286.
Guideline on pharmaceutical development of medicines for paediatric use [Internet]. London: EMA; 2013 [cited 2025 Sep 17]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmaceutical-development-medicines-paediatric-use_en.pdf.
Reflection paper: formulations of choice for the paediatric population [Internet]. London: EMA; 2006 [cited 2025 Sep 17]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-formulations-choice-paediatric-population_en.pdf.
Preis, M, Öblom, H. 3D-Printed Drugs for Children—Are We Ready Yet?. AAPS PharmSciTech. 2017;18:303–8.
Tagami T, Ito E, Kida R, Hirose K, Noda T, Ozeki T. 3D printing of gummy drug formulations composed of gelatin and an HPMC-based hydrogel for pediatric use. Int J Pharm. 2021;594(1):120118.
Beer N, Kaae S, Genina N, Sporrong SK, Alves TL, Hoebert J, et al. Magistral Compounding with 3D Printing: A Promising Way to Achieve Personalized Medicine. Ther Innov Regul Sci. 2023;57(1):26–36.
Ianno V, Vurpillot S, Prillieux S, Espeau P. Pediatric Formulations Developed by Extrusion-Based 3D Printing: From Past Discoveries to Future Prospects. Pharmaceutics. 2024;16(4):441.
Krause J, Müller L, Sarwinska D, Seidlitz A, Sznitowska M, Weitschies W. 3D Printing of Mini Tablets for Pediatric Use. Pharmaceuticals (Basel). 2021;14(2):143.
Parulski C, Bya LA, Goebel J, Servais AC, Lechanteur A, Evrard B. Development of 3D printed mini-waffle shapes containing hydrocortisone for children’s personalized medicine. Int J Pharm. 2023;642:123131.
Pistone M, Racaniello GF, Rizzi R, Iacobazzi RM, Arduino I, Lopalco I, et al. Direct cyclodextrin based powder extrusion 3D printing of budesonide loaded mini-tablets for the treatment of eosinophilic colitis in paediatric patients. Int J Pharm. 2023;632:122592.
Chatzitaki AT, Mystiridou E, Bouropoulos N, Ritzoulis C, Karavasilil C, Fatouros DG. Semi-solid extrusion 3D printing of starch-based soft dosage forms for the treatment of paediatric latent tuberculosis infection. J Pharm Pharmacol. 2022;74:1498–506.
Rycerz K, Stepien KA, Czapiewska M, Arafat BT, Habashy R, Isreb A, et al. Embedded 3D Printing of Novel Bespoke Soft Dosage Form Concept for Pediatrics. Pharmaceutics. 2019;11(12):630.
Herrada-Manchón H, Rodríguez-González D, Fernández MA, Suñé-Pou M, Pérez-Lozano P, García-Montoya E, Aguilar E.. 3D printed gummies: Personalized drug dosage in a safe and appealing way. Int J Pharm. 2020;587:119687.
Van Kampen EE, Ayyoubi S, Willemsteijn L, van Bommel KJ, Ruijgrok EJ.. The Quest for Child-Friendly Carrier Materials Used in the 3D Semi-Solid Extrusion Printing of Medicines. Pharmaceutics. 2022;15(1):28.
Pothu R, Yamsani M. Lozenges formulation and evaluation: A review. Int J Pharm Sci Rev Res. 2014;5:290–8.
Malkawi WA, AlRafayah E, AlHazabreh M, AbuLaila S, Al-Ghananeem AM. Formulation Challenges and Strategies to Develop Pediatric Dosage Forms. Children (Basel). 2022;9(4):488.
Balıkçı BB, Güneş Ü. Accuracy of liquid drug dose measurements using different tools by caregivers: a prospective observational study. Eur J Pediatr. 2024;183(2):853–62.
Monteil M, Sanchez-Ballester NM, Devoisselle JM, Begu S, Soulairol I. Regulations on excipients used in 3D printing of pediatric oral forms. Int J Pharm. 2024;662:124402.
Rodríguez-Pombo L, Awad A, Basit AW, Alvarez-Lorenzo C, Goyanes A. Innovations in Chewable Formulations: The Novelty and Applications of 3D Printing in Drug Product Design. Pharmaceutics. 2022;14(8):1732.
Januskaite P, Xu X, Ranmal SR, Gaisford S, Basit AW, Tuleu C, Goyanes A.I spy with my little eye: a paediatric visual preferences survey of 3d printed tablets. Pharmaceutics. 2020;12:11001–16.
Polat F, Kaya Z. Prevalence and Pattern of Cardiovascular Symptoms and Diseases in Pediatric Patients: Insights from a Single-Center Observational Study with a Focus on Age and Gender. Genel Tıp Derg. 2024;34(1):130–5.
Candelino M, Tagi VM, Chiarelli F. Cardiovascular risk in children: a burden for future generations. Ital J Pediatr. 2022;48(1):57.
British National Formulary for children 2022–2023. British Medical Association, Royal Pharmaceutical Society of Great Britain, the Royal College of Paediatrics and Child Health, and the Neonatal and Paediatric Pharmacists Group. London, 2022.
Mediately [Internet]. Srbija: Mediately; 2025 [cited 2025 Aug 9]. Available from: https://mediately.co/rs/home?q=popranolol.
DailyMed [Internet]. Bethesda (MD): U.S. National Library of Medicine; 2025 [cited 2025 Aug 9]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=PROPRANOLOL+HYDROCHLORIDE.
EMC [Internet]. Hertfordshire (UK): Electronic Medicines Compendium; 2025 [cited 2025 Aug 14]. Available from: https://www.medicines.org.uk/emc/search?q=%22Propranolol+Hydrochloride.
Vogelpoel H, Welink J, Amidon GL, Junginger HE, Midha KK, Möller H, et al. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol. J Pharm Sci. 2004;93(8):1945–56.
National Center for Biotechnology Information [Internet]. Bethesda (MD): National Library of Medicine (US); 2024 [cited 2025 Aug 14]. Available from: https://www.ncbi.nlm.nih.gov/.
Mariz de Avelar MH, Efraim P. Alginate/pectin cold-set gelation as a potential sustainable method for jelly candy production. LWT. 2020;123:109–19.
Kuo CC, Qin H, Acuña DF, Cheng Y, Jiang X, Shi X. Printability of hydrogel composites using extrusion-based 3D printing and post-processing with calcium chloride. J Food Sci Nutr. 2019;5:51.
Martindale: The Complete Drug Reference. 36th ed. London: Pharmaceutical Press; 2009.
Vogelpoel H, Welink J, Amidon GL, Junginger HE, Midha KK, Möller H, et al. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol. J Pharm Sci. 2004;93(8):1945–56.
Kuo CC. Semi-solid extrusion-based 3D printing of biopolymer hydrogels and their applications in food [dissertation]. [Ames (IA)]: Iowa State University; 2021.
European pharmacopoeia. 11th ed, Strasbourg: Council of Europe, 2022.
